These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 20439246)
21. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall. Jia G; Aroor AR; Sowers JR Cardiovasc Res; 2017 Jul; 113(9):1055-1063. PubMed ID: 28838041 [TBL] [Abstract][Full Text] [Related]
22. Adipocytokines in relation to cardiovascular disease. Van de Voorde J; Pauwels B; Boydens C; Decaluwé K Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981 [TBL] [Abstract][Full Text] [Related]
23. [Role of white adipose tissue in vascular complications due to obesity]. Gómez-Hernández A; Perdomo L; Escribano Ó; Benito M Clin Investig Arterioscler; 2013; 25(1):27-35. PubMed ID: 23522279 [TBL] [Abstract][Full Text] [Related]
24. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Goossens GH; Jocken JWE; Blaak EE Nat Rev Endocrinol; 2021 Jan; 17(1):47-66. PubMed ID: 33173188 [TBL] [Abstract][Full Text] [Related]
25. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids. Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237 [TBL] [Abstract][Full Text] [Related]
26. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Blüher M Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):163-77. PubMed ID: 23731879 [TBL] [Abstract][Full Text] [Related]
34. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599 [TBL] [Abstract][Full Text] [Related]
35. Role of adiposopathy and physical activity in cardio-metabolic disorder diseases. Su X; Chang D Clin Chim Acta; 2020 Dec; 511():243-247. PubMed ID: 33148528 [TBL] [Abstract][Full Text] [Related]
36. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Manna P; Jain SK Metab Syndr Relat Disord; 2015 Dec; 13(10):423-44. PubMed ID: 26569333 [TBL] [Abstract][Full Text] [Related]
37. The molecular mechanisms of obesity paradox. Antonopoulos AS; Tousoulis D Cardiovasc Res; 2017 Jul; 113(9):1074-1086. PubMed ID: 28549096 [TBL] [Abstract][Full Text] [Related]
38. Obesity and atherogenic dyslipidemia. Bamba V; Rader DJ Gastroenterology; 2007 May; 132(6):2181-90. PubMed ID: 17498511 [TBL] [Abstract][Full Text] [Related]
39. Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Zhang T; Chen J; Tang X; Luo Q; Xu D; Yu B Lipids Health Dis; 2019 Dec; 18(1):223. PubMed ID: 31842884 [TBL] [Abstract][Full Text] [Related]
40. Linking resistin, inflammation, and cardiometabolic diseases. Park HK; Kwak MK; Kim HJ; Ahima RS Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]